当前位置: 首页 > 期刊 > 《中国当代医药》 > 2012年第18期
编号:12230428
脓毒症休克心肌顿抑严重程度判断的临床研究(3)
http://www.100md.com 2012年6月25日 《中国当代医药》 2012年第18期
     [4] Dellinger RP,Levy MM,Carlet JM,et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008[J]. Crit Care Med,2008,36(1):296-327.

    [5] Waisbren BA. Bacteremia due to gram - negative bacilli ot hert han t he Salmonella : a clinical and therapeutic study[J]. AMA ArchIntern Med,1951,88(4):467-488.

    [6] Flierl MA,Rit tirsch D,Huber-Lang MS,et al. Molecular Events in the Cardiomyopathy of Sepsis[J]. Mol Med,2008,14(5-6):327-336.

    [7] Dhainaut JF,Huyghebaert MF,Monsallier JF,et al. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock[J]. Circulation,1987,75(3):533-541.

    [8] Watts JA,Kline JA,Thornton LR,et al. Metabolic dysfunction and depletion of mitochondria in hearts of septic rats[J]. J Mol Cell Cardiol,2004,36(1):141-150.

    [9] Levy RJ,Vijayasarathy C,Raj NR,et al. Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis[J]. Shock,2004,21(2):110-114.

    [10] Massion PB,Feron O,Dessy C,et al. Nitric oxide and cardiac function: Ten years after, and continuing [J]. Circ Res,2003,93(5):388-398.

    [11] Brune B. The intimate relation between nitric oxide and superoxide in apoptosis and cell survival[J]. Antioxid. Redox. Signal,2005,7(3-4):497-507.

    [12] Aviram Hochstadt,Yuval Meroz,Giora Landesberg,et al. Myocardial Dysfunction in Severe Sepsis and Septic Shock: More Questions Than Answers[J]. Journal of Cardiothoracic and Vascular Anesthesia,Vol xx,No x (Month),2011,25(3):526-535.

    [13] 杨乐,邹晓静,李树生,等. 脓毒症心肌抑制研究进展[J]. 内科急危重症杂志,2010,16(1):133-135.

    (收稿日期:2012-05-11 本文编辑:马 双), 百拇医药(陈艳丽 郭富桃)
上一页1 2 3